globalchange  > 过去全球变化的重建
DOI: 10.1371/journal.pone.0161345
论文题名:
Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon
作者: Zainab Ali; Houda Harastani; Moza Hammadi; Lina Reslan; Soha Ghanem; Farah Hajar; Ahmad Sabra; Amjad Haidar; Adlette Inati; Mariam Rajab; Hassan Fakhouri; Bassam Ghanem; Ghassan Baasiri; Bernard Gerbaka; Hassan Zaraket; Ghassan M. Matar; Ghassan Dbaibo
刊名: PLOS ONE
ISSN: 1932-6203
出版年: 2016
发表日期: 2016-8-29
卷: 11, 期:8
语种: 英语
英文关键词: Vaccines ; Vaccination and immunization ; Rotavirus infection ; Phylogeography ; Rotavirus ; Lebanon ; Gastroenteritis ; Infants
英文摘要: Introduction Globally, rotavirus (RV) is the leading cause of gastroenteritis (GE) in children. Longitudinal data about changes in RV genotype distribution and vaccine effectiveness (VE) are scarce. This study was conducted in Lebanon over 3 consecutive RV seasons to estimate the rate of RVGE hospitalization, identify RV genotypes, determine the seasonal and geographical variations, and calculate RV VE. Materials and Methods This prospective, multicenter, hospital-based surveillance study was conducted between 2011 and 2013 and enrolled children (<5 years) admitted for GE. Socio-demographic and clinical data about the current episode of GE at admission were collected. Genotypes were determined from stool samples testing positive for RV by PCR. Results Of 1,414 cases included in the final analysis, 83% were <2 years old and 55.6% were boys. Median duration of hospitalization was 4 days and 91.6% of GE cases were severe (Vesikari score ≥11). PCR testing showed that 30.3% of subjects were RV-positive of which 62.1% had fever versus 71.1% of RV-negative subjects (P = 0.001). RV was predominantly detected in the cold season from November till March (69.9%). G and P genotype pairs for all RV-positive stool specimens showed a predominance of G1P[8] in 36% (n = 154) of specimens, G9P[8] in 26.4% (n = 113), and G2P[4] in 17.8% (n = 76). RV-negative subjects were more likely to be RV-vaccinated (21%) compared to the RV-positive subjects (11.3%) (P<0.001), with a vaccine breakthrough rate of 18.8%. The ratio of RV1-vaccinated for each RV5-vaccinated subject was 7.8 and VE against RV disease was 68.4% (95%CI, 49.6%-80.2%). Conclusion RV is a major cause of GE requiring hospitalization of children under 5 years of age in Lebanon. A few genotypes predominated over the three RV seasons studied. Mass RV vaccination will likely decrease the burden of hospitalization due to RV. VE is similar to what has been observed for other middle-income countries.
URL: http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0161345&type=printable
Citation statistics:
资源类型: 期刊论文
标识符: http://119.78.100.158/handle/2HF3EXSE/23924
Appears in Collections:过去全球变化的重建
影响、适应和脆弱性
科学计划与规划
气候变化与战略
全球变化的国际研究计划
气候减缓与适应
气候变化事实与影响

Files in This Item: Download All
File Name/ File Size Content Type Version Access License
journal.pone.0161345.PDF(1124KB)期刊论文作者接受稿开放获取View Download

作者单位: Department of Pediatrics and Adolescent Medicine, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Center for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Center for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Department of Biochemistry and Molecular Genetics, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Department of Pediatrics and Adolescent Medicine, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Center for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Center for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Department of Biochemistry and Molecular Genetics, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Department of Pediatrics and Adolescent Medicine, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Center for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Department of Pediatrics and Adolescent Medicine, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Center for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Center for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Department of Biochemistry and Molecular Genetics, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Center for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Department of Biochemistry and Molecular Genetics, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Department of Pediatrics, Nini Hospital, Tripoli, Lebanon;Department of Pediatrics, Makassed General Hospital, Beirut, Lebanon;Department of Pediatrics, Rafic Hariri University Hospital, Beirut, Lebanon;Department of Pediatrics, Nabatieh Governmental Hospital, Nabatieh, Lebanon;Department of Pediatrics, Hammoud Hospital, Saida, Lebanon;Department of Pediatrics, Hôtel-Dieu de France University Hospital, Beirut, Lebanon;Center for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon;Center for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon;Department of Pediatrics and Adolescent Medicine, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Center for Infectious Diseases Research, American University of Beirut, Faculty of Medicine, Beirut, Lebanon;Department of Biochemistry and Molecular Genetics, American University of Beirut, Faculty of Medicine, Beirut, Lebanon

Recommended Citation:
Zainab Ali,Houda Harastani,Moza Hammadi,et al. Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon[J]. PLOS ONE,2016-01-01,11(8)
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zainab Ali]'s Articles
[Houda Harastani]'s Articles
[Moza Hammadi]'s Articles
百度学术
Similar articles in Baidu Scholar
[Zainab Ali]'s Articles
[Houda Harastani]'s Articles
[Moza Hammadi]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zainab Ali]‘s Articles
[Houda Harastani]‘s Articles
[Moza Hammadi]‘s Articles
Related Copyright Policies
Null
收藏/分享
文件名: journal.pone.0161345.PDF
格式: Adobe PDF
此文件暂不支持浏览
所有评论 (0)
暂无评论
 

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.